Severe Thrombocytopenia as a Manifestation of COVID-19 Infection.
Mihaela MocanRoxana Mihaela ChiorescuAndrada TirnovanBotond Sandor BuksaAnca Daniela FarcașPublished in: Journal of clinical medicine (2022)
Clinical manifestations of COVID-19 infection can range from an asymptomatic clinical form to acute respiratory distress depending on the virus gateway, viral load, host immunity, and existing comorbidities. Some patients with COVID-19 infection can present hematological changes depending on the patient's immune response and the severity of the infection. We present two different manifestations of thrombotic disorders related to COVID-19: one severe form of immune thrombocytopenia in a young woman with no comorbidities and a severe form of thrombocytopenia along with disseminated intravascular coagulation and acute urinary obstructive disease. Interestingly, both patients presented no signs of COVID-19 pneumonia. Failure to diagnose thrombocytopenia rapidly may lead to severe complications. Management with immunosuppressive corticosteroids in high doses should carefully balance the risk of bleeding versus deterioration due to infection.
Keyphrases
- drug induced
- coronavirus disease
- sars cov
- early onset
- immune response
- liver failure
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- coronary artery
- risk factors
- atrial fibrillation
- aortic dissection
- intensive care unit
- peritoneal dialysis
- toll like receptor
- middle aged
- patient reported outcomes
- hepatitis b virus
- mechanical ventilation